AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.6 Out of 5 (5749 Reviews)

Navigating investments from Canada was overwhelming until I used KSquare’s NRI services. They simplified the entire process beautifully.

Nisha Kapoor

Nisha Kapoor

Corporate Trainer

Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.

Sneha Kulkarni

Sneha Kulkarni

Healthcare Administrator

KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.

Manish Patil

Manish Patil

Operations Manager

KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.

Yash Khanna

Yash Khanna

Engineer

Thanks to KSquare, I purchased my first car without loans. The SIP plan was perfectly calculated and aligned with my budget, making everything financially smooth and stress-free.

Harsh Mehta

Harsh Mehta

I’m very happy with the NPS service at KSquare. Their personalized advice gave me the clarity I needed.

Namrata Das

Namrata Das

High School Teacher

I highly recommend KSquare for any NRI investor. Their support was proactive and always ensured I felt secure with every transaction.

Arjun Mehra

Arjun Mehra

Cybersecurity Expert

KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.

Harsh Vardhan

Harsh Vardhan

Energy Analyst

KSquare’s SIP has brought structure to my investment plan. It's great for disciplined investing, and the automation ensures I never miss a payment. Very happy with the service so far!

Ankit Desai

Ankit Desai

Entrepreneur

KSquare’s approach to New Fund Offerings really impressed me. I finally feel confident participating in something I once thought was too complicated.

Lara Dhamija

Lara Dhamija

Content Editor

FAQ's

Frequenlty Asked Question

What is the minimum amount to start investing with KSquare?

NRIs can begin with as little as ₹1,000 per month depending on the investment vehicle, offering flexible entry points.

What is the minimum amount required to start a SIP?

You can begin a SIP with as little as ₹500 per month, making it accessible for investors of all income levels.

Can I nominate someone for my NPS account?

Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.

Is SIP suitable for business owners too?

SIP is equally beneficial for business owners, helping them invest steadily despite fluctuating income.

Are SIPs better than lump sum investments?

SIPs help average out market volatility over time, making them a safer and more consistent choice than lump sum investing.

What documents are needed to invest in an NFO through KSquare?

You’ll need KYC-compliant documents like PAN, Aadhaar, and bank details to invest in NFOs through KSquare.

Can I increase my SIP amount later?

Yes, KSquare allows you to modify or increase your SIP contributions easily as your income or goals change.

How are NPS returns calculated?

NPS returns depend on the performance of the equity, corporate debt, and government bond funds you select within your portfolio.

App Store